EPIQ Series Diagnostic Ultrasound System vs Tempus ECG-AF

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 60/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.
EPIQ Series Diagnostic Ultrasound System
by Philips
VS
Tempus ECG-AF
by Tempus AI, Inc.

AI Verdict

Tool A is a comprehensive AI-powered diagnostic ultrasound system designed for broad imaging applications across multiple specialties, including cardiology. Tool B is a specialized AI algorithm focused on analyzing ECGs to predict the risk of atrial fibrillation in a specific patient demographic. While both leverage AI in cardiology, Tool A provides advanced imaging capabilities, whereas Tool B offers a predictive risk assessment.

Choose EPIQ Series Diagnostic Ultrasound System if…

Choose the Philips EPIQ Series Diagnostic Ultrasound System if your facility requires a versatile, high-performance imaging solution for comprehensive diagnostic needs across multiple specialties. This system is ideal for detailed anatomical and functional assessments, offering AI-powered imaging and advanced workflow features to enhance diagnostic confidence in cardiology, OB/GYN, radiology, and more.

View EPIQ Series Diagnostic Ultrasound System →

Choose Tempus ECG-AF if…

Choose Tempus ECG-AF if your clinical objective is to proactively identify older patients (65+) at increased risk of developing new-onset atrial fibrillation within the next year. This AI-based algorithm is best suited for integrating into existing cardiology workflows to support earlier identification and follow-up for at-risk individuals without pre-existing AF, leveraging standard 12-lead ECG recordings.

View Tempus ECG-AF →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature EPIQ Series Diagnostic Ultrasound System Tempus ECG-AF
Pricing Unknown Contact vendor
Deployment Unknown Software solution, integrated into healthcare facility systems with advanced cardiology algorithms.
BAA Available Unknown Yes AI-estimated
FDA Status Unknown Yes AI-estimated
HIPAA Unknown Yes AI-estimated

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature EPIQ Series Diagnostic Ultrasound System Tempus ECG-AF
Name EPIQ Series Diagnostic Ultrasound System Tempus ECG-AF
Description The Philips EPIQ Series Diagnostic Ultrasound System offers premium AI-powered imaging and advanced workflow solutions for enhanced diagnostic confidence across diverse clinical applications. Tempus ECG-AF is an FDA-cleared AI-based algorithm that analyzes 12-lead ECG recordings to identify patients aged 65 or older at increased risk of developing atrial fibrillation/flutter (AF) within the next 12 months, supporting earlier identification and follow-up.
Company Philips Ultrasound Tempus AI, Inc.
Categories Cardiology AI, OB/GYN AI, Radiology & Imaging AI Cardiology AI
Specialties Cardiology, Emergency Medicine, Interventional Radiology, Obstetrics & Gynecology, Orthopedics, Pediatrics, Radiology, Urology Cardiology, Geriatrics, Internal Medicine
Core AI Application AI-powered imaging, Anatomical Intelligence Ultrasound (AIUS), AI-Enhanced Imaging & Automated Measurements AI-based algorithm for 12-lead ECG analysis to identify patients aged 65 or older at increased risk of developing atrial fibrillation/flutter (AF) within 12 months.

Videos

Demos, reviews, and walkthroughs featuring EPIQ Series Diagnostic Ultrasound System and Tempus ECG-AF.

Loading videos…
Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

The Philips EPIQ Series Diagnostic Ultrasound System is designed for premium AI-powered imaging and advanced workflow across diverse diagnostic clinical applications. Tempus ECG-AF is an AI-based algorithm that analyzes 12-lead ECG recordings to identify patients aged 65 or older at increased risk of developing atrial fibrillation/flutter (AF) within the next 12 months.
The Philips EPIQ Series utilizes AI for enhanced imaging, automated measurements, and workflow solutions in ultrasound diagnostics, including features like Anatomical Intelligence Ultrasound (AIUS) and AI-Enhanced Imaging. Tempus ECG-AF employs an AI-based algorithm specifically for predictive risk analysis of 12-lead ECGs to detect signs associated with new onset AF.
The Philips EPIQ Series is intended for a broad range of clinical specialties and patient populations for diagnostic imaging. Tempus ECG-AF is specifically for patients aged 65 or older without pre-existing AF, pacemakers, ICDs, or recent cardiac surgery, to identify increased risk of new-onset AF within 12 months.
The Philips EPIQ Series is a standalone diagnostic ultrasound system. Tempus ECG-AF is compatible with FDA authorized resting 12-lead ECGs from GE Medical Systems and Philips Medical Systems.

More Comparisons

Assert-IQ vs Rapid Enterprise Platform
AISAP Cardio vs Rapid Enterprise Platform
AngioWaveNet vs Rapid Enterprise Platform
CorVista System with PH Add-On vs Rapid Enterprise Platform

More matchups featuring EPIQ Series Diagnostic Ultrasound System or Tempus ECG-AF

AI Tool Finder
AI-powered search. Results may not be comprehensive.